GlassScriptPhysician profile
Erin K Hill
NPI 1215174404
$247.96
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2021: $17.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $54.94 | 2019 | |
| Abbvie INC. | $35.21 | 2019 | |
| Therapeuticsmd, INC. | $18.63 | 2019 | |
| Avion Pharmaceuticals | $18.42 | 2019 | |
| Ge Healthcare | $17.50 | 2021 | |
| Smith+Nephew, INC. | $17.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.19 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.55 | 2019 | |
| Boston Scientific Corporation | $15.38 | 2019 | |
| Lupin INC. | $14.68 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.30 | 2019 | |
| Pfizer INC. | $11.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.